Lv4
570 积分 2024-08-13 加入
Commercial Route Development Toward PF-07265807, an AXL-MER Inhibitor Oncology Candidate
2天前
已完结
A Chiral Pool Strategy for the Synthesis of a SMARCA2 Degrading PROTAC
3天前
已完结
Optimized Synthesis of Indole Carboxylate Metallo-β-Lactamase Inhibitor EBL-3183
4天前
已完结
Efficient and Scalable Diastereoselective Synthesis of ((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol Hydrochloride
5天前
已完结
Novel and Cost-Effective Manufacturing Process Development of Daprodustat
9天前
已关闭
Preclinical Toxicology Supply for a Complex API Enabled by Asymmetric Catalysis and Rapid Chemical Development: IL-17A Inhibitor LY3509754
17天前
已完结
Stereoselective Synthesis of Mirogabalin via 1,4-Selective Addition of Lithioacetonitrile to Alkylidene Malonate
23天前
已完结
Development of a Scalable Manufacturing Process for AB-343 Drug Substance: A Potential Candidate for the Treatment of Coronavirus Infections
25天前
已完结
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
28天前
已完结
Commercial Route Development of Sigma-2 Receptor Modulator, CT1812 Leveraging Photoflow, and HTS Technologies
1个月前
已完结
皖公网安备34019202002308
